Page last updated: 2024-11-02

pioglitazone and Acute Necrotizing Pancreatitis

pioglitazone has been researched along with Acute Necrotizing Pancreatitis in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Treatment with pioglitazone decreased the level of amylase activity, proinflammatory factors IL-6 and TNF-α, ameliorated pancreatic histological score, and upregulated the expression of PPARγ mRNA."1.37Pioglitazone: a promising therapeutic tool in sodium taurocholate-induced severe acute pancreatitis. ( Chen, LQ; Jiang, JP; Wang, J; Xu, K; Xu, P, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, P1
Xu, K1
Wang, J1
Jiang, JP1
Chen, LQ1

Other Studies

1 other study available for pioglitazone and Acute Necrotizing Pancreatitis

ArticleYear
Pioglitazone: a promising therapeutic tool in sodium taurocholate-induced severe acute pancreatitis.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:4

    Topics: Amylases; Animals; Hypoglycemic Agents; Interleukin-6; Male; Pancreas; Pancreatitis, Acute Necrotizi

2011